Carregant...
Interaction of molecular alterations with immune response in melanoma
Major advances have been made in melanoma treatment with the use of molecularly targeted- and immuno- therapies, with numerous regimens now FDA-approved for patients with stage IV disease. However therapeutic resistance remains an issue to both classes of agents, and reliable biomarkers of therapeut...
Guardat en:
| Publicat a: | Cancer |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6105277/ https://ncbi.nlm.nih.gov/pubmed/28543700 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.30681 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|